FDA Drug Application (208341) for EPCLUSA by GILEAD SCIENCES INC

Back to FDA Applications sponsored by GILEAD SCIENCES INC

Application Number208341
Product Number001
FormTABLET;ORAL
Dosage400MG;100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEPCLUSA
Active IngredientSOFOSBUVIR; VELPATASVIR

Active IngredientCount
List of drugs with Active Ingredient SOFOSBUVIR3


Back to FDA Applications sponsored by GILEAD SCIENCES INC